Kineta is building next-generation immunotherapies to transform patients’ lives. Our immuno-oncology focused pipeline addresses the major challenges with current cancer therapy.
Immunosupression
Exhausted T cells
Poor tumor immunogenicity
Immunosupression
Exhausted T cells
Poor tumor immunogenicity